VeriMommipa-cocoyl sarcosinate est-il sûr pendant la grossesse ?
No harmonised reproductive hazard classification (no ECHA Annex VI H360/H361 found) and the Cosmetic Ingredient Review (CIR) safety assessment of sarcosines/sarcosinates concluded these ingredients are 'safe as used' (approved for rinse‑off and limited leave‑on use). No peer‑reviewed evidence of reproductive or developmental toxicity or endocrine disruption specific to cocoyl sarcosinates was identified. Sources: CIR safety assessment (CIR/PubMed) and industry/CosmeticsInfo summary.
Pregnancy-safe products containing mipa-cocoyl sarcosinate
Related ingredients
Frequently asked questions
- mipa-cocoyl sarcosinate est-il sûr pendant la grossesse ?
- No harmonised reproductive hazard classification (no ECHA Annex VI H360/H361 found) and the Cosmetic Ingredient Review (CIR) safety assessment of sarcosines/sarcosinates concluded these ingredients are 'safe as used' (approved for rinse‑off and limited leave‑on use). No peer‑reviewed evidence of reproductive or developmental toxicity or endocrine disruption specific to cocoyl sarcosinates was identified. Sources: CIR safety assessment (CIR/PubMed) and industry/CosmeticsInfo summary.
- mipa-cocoyl sarcosinate est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: no evidence of reproductive/developmental hazard or mechanism suggesting lactation/transfer concerns; CIR concluded sarcosinates are safe as used. No studies showing placental or milk transfer or effects on neonates were found.
- mipa-cocoyl sarcosinate est-il sûr pour la peau de bébé ?
- No specific developmental/infant toxicity evidence; CIR states sarcosinates are safe in rinse‑off and at limited concentrations in leave‑on use. Dermal absorption data are limited, but sarcosinate surfactants are rinsed and not described as non‑absorbable; per the scoring rules, adult exposure scored 0 and infant exposure increased by +1 because infant skin has higher surface‑area‑to‑weight and an immature barrier. No infant‑specific hazard or mechanism data were found.
- Comment VeriMom évalue-t-il mipa-cocoyl sarcosinate ?
- VeriMom évalue mipa-cocoyl sarcosinate à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à mipa-cocoyl sarcosinate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à mipa-cocoyl sarcosinate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.